Virtual Reality Distraction for Pain and Anxiety in Hemodialysis Patients
NCT ID: NCT07334522
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
150 participants
INTERVENTIONAL
2025-12-25
2026-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Determine the effect of the distraction technique using virtual reality on pain and anxiety levels during arteriovenous fistula needle insertion in hemodialysis patients.
3. Find out the differences in the level of pain and anxiety after using virtual reality with regard to the demographic and clinical data of the sample.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Distraction During Arteriovenous Fistula Puncture
NCT05399199
Virtual Reality and Guided Imagery to Reduce Procedural Pain
NCT06835712
Effect of Virtual Reality on Cannulation-Related Procedural Pain, Distress and Comfort Level in Hemodialysis Patients
NCT07281144
The Effect of Video Streaming with Virtual Reality Glasses on Pain and Anxiety
NCT06776497
Virtual Reality for Pain and Anxiety Relief During Peripheral Angioplasty
NCT07057752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hemodialysis remains the primary life-sustaining treatment for these patients. To perform hemodialysis efficiently, a reliable vascular access is required, with the arteriovenous fistula (AVF) being the gold standard. However, the procedure requires the insertion of large-gauge needles into the fistula repeatedly (usually three times a week), which is often associated with significant pain and distress.
Needle phobia, anticipatory anxiety, and procedure-related pain are common challenges among hemodialysis patients. Unmanaged pain and anxiety can lead to poor adherence to treatment, adverse physiological responses (such as hypertension and tachycardia), and a reduced quality of life.
Virtual Reality (VR) is an immersive technology that draws the patient's attention away from the noxious stimulus by creating a simulated environment. The study aims to evaluate the efficacy of VR as a distraction method to reduce pain and anxiety during AVF cannulation in hemodialysis patients compared to standard care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
The intervention protocol involves the use of virtual reality distraction as follows:
* 2 minutes before needle insertion: patients wear the VR headset to establish immersion.
* 3 minutes during needle insertion: VR continues throughout the cannulation procedure.
* Immediately after completion of needle insertion: the VR headset is removed.
Measurement Strategy
* Anxiety: assessed using the Visual Analogue Scale for Anxiety (VAS-A), measured before and after the intervention (for pre-test groups).
* Pain: assessed using the Visual Analogue Scale (VAS), measured only after the
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality Group
Participants in this group will receive distraction therapy using Virtual Reality (VR) glasses during the AVF insertion. The VR session starts 2 minutes before the procedure and continues for 3 minutes during the insertion. Utilizing the Solomon Four-Group Design, this group is randomly subdivided into two subgroups: in Subgroup A, anxiety is assessed before the intervention, while in Subgroup B, no pre-test assessment is performed. Both subgroups undergo post-test measurement for pain and anxiety immediately after the procedure.
Virtual Reality
The intervention involves using VR glasses to provide audiovisual distraction. Participants will watch a 360-degree underwater video with calming music. The VR session starts 2 minutes before the procedure and continues for 3 minutes during the insertion
Control Group
Participants in this group will receive standard routine nursing care for AVF insertion without any additional distraction techniques. Utilizing the Solomon Four-Group Design, this group is randomly subdivided into two subgroups: in Subgroup C, anxiety is assessed before the procedure, while in Subgroup D, no pre-test assessment is performed. Both subgroups undergo post-test measurement for pain and anxiety immediately after the procedure
standard of care
Routine nursing care for AVF insertion, including skin disinfection and needle insertion according to the hospital's standard protocols, without any additional distraction techniques.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality
The intervention involves using VR glasses to provide audiovisual distraction. Participants will watch a 360-degree underwater video with calming music. The VR session starts 2 minutes before the procedure and continues for 3 minutes during the insertion
standard of care
Routine nursing care for AVF insertion, including skin disinfection and needle insertion according to the hospital's standard protocols, without any additional distraction techniques.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients using a functioning arteriovenous fistula (AVF).
* Conscious, oriented, and able to communicate.
* Normal or corrected vision and hearing suitable for VR use.
* Patients capable of giving written informed consent.
Exclusion Criteria
* Use of Central Venous Catheter (CVC) or Arteriovenous Graft (AVG).
* Use of analgesics or sedatives within 4 hours before the procedure.
* Facial wounds or eye infections preventing VR use.
* Hemodynamic instability or cognitive impairment.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karbala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Astabraq Rassoul Hussein Abass
Graduate Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Astabraq R Hussein, MGS
Role: PRINCIPAL_INVESTIGATOR
kerbala heath department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imam Al-Hassan Al-Mujtaba Teaching Hospital
Karbala, , Iraq
Imam Al-Hussain Teaching Hospital
Karbala, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UOK.CON.25.0100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.